To view this email as a web page, click here.

 
FEBRUARY 2019 ISSUE ALERT
Volume 11, Number 2
Get the full February 2019 digital edition here
Topical immunomodulators help chronic ocular allergic disease, New CA law affects all VSP providers, Essilor forms task force to combat rise of myopia, and much more available in our digital edition.
Read more
 
Topical immunomodulators help chronic ocular allergic disease
image description here It’s allergy season, and patients are feeling the itch. Consider this treatment option to offer patients another choice in combatting chronic disease. Find out how.

Find out
 
New CA law affects all VSP doctors
image description here A new law in California affects all ODs participating in VSP. Find out how this law affects ODs and how to reduce the risk of an audit.

Learn more
 
Essilor forms task force to combat rise of myopia
image description here Essilor announced the launch of a 14-member task force of eyecare professionals to recommend protocol for treating and managing the condition. Members participated in a Q&A session to discuss the increasing epidemic.

Read more
 
MORE FROM OUR FEBRUARY ISSUE
 
Optometry’s role in the opioid epidemic
Choose your words carefully with surgery patients
Intersection of artificial intelligence with epigenetics
A look at the latest and upcoming pharmaceutical patents
Innovative mobile technology targets low vision
The case of the single fixed pupil
Q&A: Contact lens research and innovation, playing sport, moving to Canada from the UK
 
RESOURCE CENTER
 
Allergy Resource Center
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.